CIK 0001098972 · Accelerated filer<br>Smaller reporting company
AGENUS INC
Sign in to watch- Ticker
- AGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061562417
- Phone
- 781-674-4410
- Business address
- 3 FORBES ROAD, LEXINGTON, MA, 02421
- Former names
- ANTIGENICS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-29 | ARMEN GARO H See Remarks | Grant or award | +4,769 | $3.42 | $16K | 113,093 |
| 2024-11-15 | ARMEN GARO H See Remarks | Grant or award | +5,997 | $2.72 | $16K | 108,324 |
| 2024-11-14 | KLASKIN CHRISTINE M PFO & PAO | Grant or award · Stock Option | +10,000 | 10,000 | ||
| 2024-11-14 | ARMEN GARO H See Remarks | Grant or award · Stock Option | +600,000 | 600,000 | ||
| 2024-11-14 | Buell Jennifer Chairman Executive Council | Grant or award · Stock Option | +300,000 | 300,000 | ||
| 2024-11-14 | O'Day Steven J Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2024-11-01 | ARMEN GARO H See Remarks | Grant or award | +4,207 | $4.05 | $17K | 102,327 |
| 2024-10-18 | ARMEN GARO H See Remarks | Grant or award | +3,530 | $4.62 | $16K | 98,300 |
| 2024-10-04 | ARMEN GARO H See Remarks | Grant or award | +3,349 | $4.87 | $16K | 94,770 |
| 2024-10-01 | WIINBERG ULF Director | Grant or award · Deferred Stock Units | +3,423.48 | 19,500.66 |
Page 6 of 6 · 110 trades